High mobility group 1 protein (HMG1) has traditionally been considered a structural component of chromatin, possibly similar in function to histone H1. In fact, at the onset of Xenopus and Drosophila development, HMG1 appears to substitute for histone H1: HMG1 is abundant when histone H1 is absent after; the midblastula transition histone H1 largely replaces HMG1. We show that in early mouse embryos the expression patterns of HMG1 and histone H1 are not complementary. Instead, HMG1 content increases after zygotic genome activation at the same time as histone H1. HMG1 does not remain associated to mitotic chromosomes either in embryos or somatic cells. These results argue against a shared structural role for HMG1 and histone H1 in mammalian chromatin.
Introduction
High-mobility group 1 protein (HMG1) is an abundant and highly conserved component of eukaryotic nuclei. HMG1 and its close relative HMG2 are present in all mammalian tissues and cells, and HMG1-like proteins also exist in yeast, protozoa and plants (Bianchi, 1995; reviewed in Bustin and Reeves, 1996) .
HMG1 is considered to be a chromatin component because it can bind to DNA, but without sequence specificity. Its two DNA-binding domains, which belong to the HMG-box class, bind DNA from the minor groove side, locally widening the groove and causing the double helix to bend sharply. As a consequence, HMG1 has a high affinity for DNA containing sharp bends or kinks, such as fourway junctions or DNA covalently modified with the antitumor drug cisplatin, where the minor groove is wider than in B-form DNA. Conversely, HMG1 has the ability to transiently introduce bends or kinks into linear DNA, and can promote the formation of nucleoprotein complexes where the DNA follows constrained, curved paths. Thus, HMG1 is an 'architectural' protein, or DNA chaperone.
HMG1 appears to interact physically with several homeodomain-containing transcription factors (HOX and OCT), with steroid hormone receptors (SHRs), with components of the basal transcription machinery, with the V(D)J recombinase RAG1/RAG2, and with the p53 oncoprotein (Zwilling et al., 1995; Shykind et al., 1995; Zappavigna et al., 1996; Agrawal and Schatz, 1997; Boonyaratanakornkit et al., 1998; Jayaraman et al., 1998) . In every case where this has been investigated, contact is established between either of the HMG-boxes of HMG1 and the DNA-binding domain of the partner, even in the absence of DNA. In the presence of DNA, the interaction between HMG1 and the partner facilitates the formation of the complex and/or enhances its stability. In transfection experiments, increasing the nuclear concentration of HMG1 results in enhanced trans-activation of reporter genes by HOX, OCT or SHR transcription factors (Zwilling et al., 1995; Zappavigna et al., 1996; Boonyaratanakornkit et al., 1998) . Nonetheless, the architectural capacity of HMG1 may be crucial in the formation or maintenance of the most common nucleoprotein complex containing bent DNA in eukaryotic cells, the nucleosome.
HMG1 is ubiquitous and is sufficiently abundant to associate with a significant fraction of nucleosomes. The proposal that HMG1 might promote the formation of nucleosomes , or stabilize nucleosomes by binding at the DNA crossover site (Lilley, 1992) , is now supported by the observation that histone H1 and HMG1 share several properties. Xenopus HMG1 (xHMG1) binds to nucleosomes in vitro in much the same way as histone H1 Ura et al., 1996) ; HMG-D, a Drosophila HMG1-like protein, is a structural component of condensed metaphase chromosomes ; histone H1 also binds to four-way junctions (Varga-Weisz et al., 1993) . Moreover, xHMG1 and HMG-D appear to substitute for histone H1 during early embryogenesis: they are stockpiled in the eggs, at a time when histone H1 is absent, and are largely lost after its appearance (Dimitrov et al., 1993; Dimitrov et al., 1994; Ner and Travers, 1994) . This has prompted the suggestion that HMG1 might be an alter ego of histone H1, endowed with similar overall properties but specifically adapted to perform subtly different functions, perhaps connected to rapid genome replication or the absence of transcription before the midblastula transition (MBT).
In order to elucidate whether HMG1 performs overlapping or complementary roles with histone H1, we have undertaken studies of its localization, its association with chromatin, and its expression pattern. We showed previously that in mammalian cells in culture, HMG1 and histone H1 differ widely in their ability to associate to chromatin (Falciola et al., 1997) . During metaphase, HMG1 detaches from condensed chromosomes; it is also released from interphase chromatin if the nuclear membranes are permeabilized with detergents. Histone H1, on the other hand, remains firmly bound to chromatin both in permeabilized interphase cells and in condensed metaphase chromosomes. These findings might be easily reconciled with the idea that histone H1 and HMG1 have similar properties and functions if histone H1 saturated the target sites for HMG1 in the chromatin of adult cells.
In the present work, we investigate the association of HMG1 with chromatin in very early mouse development, a period when histone H1 has been reported to be in very low abundance (Clarke et al., 1992) . We show that HMG1 is present in the germinal vesicle (GV) of unfertilized mouse eggs, but that its concentration drops in the one-cell zygote, contrary to the abundance of xHMG1 in early embryos. Zygotic transcription of hmg1 began as early as the twocell stage, with high levels of transcription at the four-cell and morula stages. Additional regulation of the nuclear content of HMG1 at the level of protein and/or mRNA stability was observed in blastocysts. The affinity of HMG1 for chromatin was similar to that observed in somatic cells; it did not remain associated with chromosomes during metaphase in preimplantation embryos. This indicates that HMG1 does not have a role as a substitute for histone H1 during early embryogenesis in the mouse. For analysis of hmg1 transcriptional activity in preimplantation embryos, the hmg1 promoter/enhancer regulatory sequences containing the major transcription start site, the first exon, the first intron and part of the second exon were linked to the cDNA coding for the recombinant cytosolic form of firefly luciferase. (B) The same hmg1 regulatory sequences as in (A) (EcoRI* to HindIII#) were used to produce HA epitope-tagged HMG1 protein in preimplantation embryos. The HA epitope (bold and underlined) was inserted into exon 2 of the hmg1 gene in frame between amino acids 1 and 2. The exons are numbered; black boxes indicate untranslated sequences and white boxes, translated sequences. (C) Strategy for the RT-PCR amplification of the 2.5, 1.5, and 1.2 kb hmg1 transcripts. Three alternative polyadenylation sites exist in the 3′ untranslated region of the hmg1 gene. To amplify the three transcripts, three different hmg1 specific 5′ primers located upstream of each of the polyadenylation signals were used in conjunction with the same 3′ primer complementary to the polyA tail.
Results

Preimplantation expression profiles of hmg1 transcripts
As a first step in assessing the expression profile of the hmg1 gene during early embryogenesis in the mouse, we measured the level of hmg1 transcripts at different developmental stages.
In mouse, Northern blotting revealed three hmg1 mRNAs ( Fig. 2A) . The same result has been observed previously in Chinese hamster and human cells (Lee et al., 1987; Wen et al., 1989) : the 1.5 kb transcript was the major species, followed by the 2.5 kb product, with a very minor contribution from the 1.2 kb transcript (the shorter transcript is clearly visible only after long exposures). As in other mammals, the three transcripts differ at their 3′ untranslated region through the use of alternative polyadenylation sites. The sequence of the longer transcript in the mouse was previously reported by Yotov and St.-Arnaud (1992) . To follow the expression dynamics of each individual transcript, we performed reverse transcription polymerase chain reaction (RT-PCR) using three different hmg1 specific 5′ primers in combination with a primer complementary to part of the linker-oligo(dT) used during the reverse transcription reaction (Shuldiner et al., 1991; Fig. 1) . This strategy also guarantees that no PCR product could come from DNA adventitiously present in the RNA preparation. Amplification of DNA is usually avoided by treating samples with DNase and/or using exon-specific primers separated by an intronic region. Neither conventional strategy could be used here because DNase treatment of the small quantities of RNA isolated from preimplantation embryos yielded inconsistent results, and because the mouse genome contains many intronless pseudogenes related to the hmg1 gene (Ferrari et al., 1994) .
All three hmg1 transcripts were detected in preimplantation embryos as RT-PCR products giving strong signals after hybridization with an hmg1-specific probe (Fig. 2B,  C) . The relative abundance of each transcript cannot be gauged directly by comparing the signal from one transcript to the signal from another transcript, since amplification conditions were optimized for each individual transcript. However, abundance did correspond to the signal intensity within each time series for an individual transcript: this comparison revealed that the abundance of each transcript at the blastocyst stage is roughly comparable with the abundance in mouse kidney or 3T3 cells: the 1.5 kb transcript is prevalent, the 2.5 kb transcript is strongly represented, and the shorter 1.2 kb transcript is scarcely significant.
Our analysis revealed a significant fluctuation in the level of hmg1 transcripts during the development of preimplantation embryos. The major 1.5 kb transcript was present in germinal vesicle stage oocytes, followed by an abrupt loss of this maternal stock in transcriptionally inactive mature oocytes. Low levels of maternal 1.5 kb mRNA persisted through to the two-cell stage before zygotic transcription increased levels considerably at the four-cell stage, with a second increase at the morula stage; no further increase was observed at the blastocyst stage. The second most abundant 2.5 kb hmg1 transcript exhibited a very similar profile of expression, although the decrease in maternal transcripts in mature oocytes and one-cell zygotes was somewhat less dramatic. In contrast, the low-abundance 1.2 kb transcript had a different preimplantation profile: the maternal stock remained stable following maturation and fertilization before increasing at the two-cell stage; the level of the transcript then remained relatively stable during subsequent cleavage stages. 
Location and abundance of native murine HMG1 in preimplantation embryos
To determine whether the abundance of the HMG1 protein in preimplantation embryos reflected the expression profile of the two major hmg1 transcripts, confocal immunofluorescence studies were carried out (Fig. 3A) . The HMG1 protein was present in the germinal vesicle but was much less abundant in one-and two-cell embryos. HMG1 clearly increased in four-cell embryos and remained abundant in subsequent cleavage stages. At all developmental stages, HMG1 was uniformly distributed throughout the nuclear volume with the exception of nucleoli, where it was completely absent. At mitosis (Fig. 3B) , in contrast to histone H1, HMG1 did not remain associated with chromatin in condensed chromosomes and became distributed throughout the cytoplasm, as previously observed in somatic cells (Falciola et al., 1997) .
A more accurate semi-quantitative analysis of nuclear HMG1 content was performed by integrating the signal from optical sections of the nuclei at various embryonic stages (Fig. 4) . There was a significant increase in both the quantity and concentration of HMG1 in interphase nuclei from the one-to four-cell stages. At the eight-cell stage, the nuclear concentration of HMG1 continued to increase but this was essentially a result of reduced nuclear volume, as the total amount of protein was not different from that observed at the four-cell stage. By the blastocyst stage, further increases were observed in both concentration and total abundance.
Transcription from the hmg1 promoter/enhancer during preimplantation development
Both the RT-PCR profiles and immunofluorescence analysis of the native protein indicate a very different pattern for murine HMG1 as compared with HMG1 homologues in early Xenopus and Drosophila embryos. In these species, HMG1 homologues are abundant prior to the major activation of the zygotic genome (ZGA), followed by a decrease around the mid-blastula transition. In contrast, in mouse embryos, HMG1 was in low abundance prior to major ZGA and appeared to be upregulated thereafter.
To determine the transcriptional status of the hmg1 gene during the preimplantation period, we microinjected the pmHMG1tag plasmid, which contains the complete hmg1 genomic locus and expresses HMG1 protein tagged at the N-terminus with the HA epitope. The tagged protein was followed during the preimplantation period by confocal immunofluorescence (Fig. 5) . The protein appeared in two-cell embryos, increased in nuclear concentration at the four-and eight-cell stages, and remained very abundant in the nuclei of blastocysts. The similarity in expression profile between the native and tagged HMG1 proteins ensures that the HMG1 protein detected after the two-cell stage derives predominantly from transcription of the hmg1 gene, and is not carried over from the germinal vesicle stage or expressed from stockpiled maternal transcripts.
To determine the transcriptional activity of the hmg1 promoter/enhancer during the preimplantation period, a plasmid was constructed in which the hmg1 regulatory sequences controlled the expression of a cDNA coding for a recombinant cytosolic form of firefly luciferase. We first determined that the half-life of the cytosolic luciferase was only 2-3 h in early mouse embryos (see Section 4). This half-life was sufficiently short, compared with the developmental time intervals at which expression was analyzed, that luciferase activity at any specific time could be taken as equivalent to the specific transcriptional activity at that time.
After microinjection of the plasmid into the male pronucleus of one-cell embryos, the construct was found to be transcriptionally active at the two-cell stage, increased in activity during the four-cell stage, and remained at this level during the eight-cell stage (Fig. 6) . There was then a further increase in transcriptional activity at the morula stage before an apparent decline in blastocysts. The same expression profile was obtained after microinjection by two different operators, and the same result was observed when the expression from living individual embryos was monitored throughout the preimplantation period by repeated photon counting imaging at different stages (Fig. 7) . With the exception of the drop in luciferase expression at the Fig. 4 . The relative amount and concentration of HMG1 in nuclei at different developmental stages. As nuclear volume (X) decreases during the preimplantation period, both the nuclear amount (O) and concentration of HMG1 (♦) increase. Mean values ± standard error are given; the number of nuclei analyzed at each stage is indicated in parentheses below the abscissa. Details on the calculations are given in the Section 4. blastocyst stage, this profile agreed very well with that observed for the major 1.5 kb transcript in the RT-PCR analysis.
The increased amount of tagged HMG1 in blastocyst nuclei injected with pmHMG1tag relative to earlier cleavage stages is in contrast to the drop in luciferase expression observed in blastocysts injected with pmHMG1-luc (Figs. 5 and 6). The possibility of a marked difference in plasmid loss during the morula-blastocyst transition between pm HMG1tag and pmHMG1-luc is very unlikely, given that the expression profiles of the two plasmids agree until the morula stage. More likely, HMG1 mRNA or HMG1 protein, or both, are stable molecules, so that the total amount of protein increases even after a recent drop in the rate of transcription.
Discussion
HMG1 protein has long been considered a structural component of chromatin (van Holde, 1988) and previous work had shown that in Xenopus, HMG1 can bind to nucleosomes and is an abundant nuclear component during early embryogenesis, when the content of histone H1 is very low (Dimitrov et al., 1994; Nightingale et al., 1996) . A similar situation was also described in Drosophila, where the HMG1-like protein HMG-D is associated to chromosomes during early embryogenesis, when histone H1 is absent . This prompted the suggestion that HMG1 and histone H1 might perform similar functions. However, we previously showed that in cultured mammalian cells HMG1 is weakly associated to interphase chroma- Fig. 5 . Expression of epitope-tagged HMG1 in preimplantation embryos. Epitope-tagged HMG1 was expressed after microinjection of pmHMG1tag into onecell pronuclei and detected by immunolabeling. All images were taken at identical contrast and brightness settings on the confocal microscope. 2c, two-cell; 4c, four-cell; 8c, eight-cell; Bl, blastocyst. The scale bar in the two-cell image represents 15 mm, and is applicable to all images.
tin and is not a component of condensed nucleosomes (Falciola et al., 1997) . A possible explanation to reconcile these observations is that in differentiated mammalian cells histone H1 competes with HMG1 for the same sites on nucleosomal DNA or condensed chromosomes, while in early embryogenesis HMG1 is free to bind to nucleosomes due to the absence of histone H1.
In the present work, we have examined the expression of HMG1 during mouse preimplantation development, when the content of somatic histone H1 is very low. We observed a very good correlation at all developmental stages between HMG1 protein concentration, the level of the three hmg1 transcripts, and the level of transcription supported by the hmg1 promoter/enhancer. The only exception occurred at the blastocyst stage, when transcription from the hmg1 promoter/enhancer declined, while HMG1 protein continued to accumulate: this suggests that HMG1 protein or its mRNA, or both, are relatively stable.
In the mouse, HMG1 was not stocked in abundance in oocytes, nor were hmg1 transcripts. Instead, zygotic transcription was observed from the hmg1 gene in two-cell embryos and the nuclear content of HMG1 protein increased significantly at the four-cell stage. Transcriptional activity of the hmg1 promoter/enhancer attained high levels at the four-cell stage, and was followed by a further burst in morula, just prior to the first cellular differentiation occurring at the blastocyst stage. Incidentally, the profile of expression driven by the hmg1 promoter/enhancer regulatory sequences, combined with the very high proportion of expressing embryos after plasmid microinjection, make this a very useful construct for studying the developmental consequences of overexpressing proteins during the preimplantation period in the mouse.
Throughout preimplantation development, HMG1 protein always localized to the nucleus of interphase cells, but diffused to the cytoplasm and was never associated to condensed chromosomes in cells during mitosis. This occurred even in the absence of significant levels of histone H1, indicating that the exclusion of HMG1 from condensed chromosomes was not due to competition. Moreover, the level of HMG1 protein after the first nuclear divisions was low, and thus could not be in excess with respect to binding sites in condensed chromosomes.
In view of these data, the proposal that HMG1 substitutes for histone H1 in a shared structural role in organizing chromatin in Xenopus and Drosophila embryos can not be generalized as a common feature of early embryonic development. Instead, the substitution of HMG1 for histone H1 in Xenopus and Drosophila embryos may be a particular characteristic of the more extended and less stable, rapidly replicating chromatin found in these species prior to the MBT Travers, 1994, Nightingale et al., 1996) . In further Fig. 6 . Transcriptional activity from the hmg1 promoter/enhancer during preimplantation development. The luciferase activity profile (mean ± standard error) is represented by filled circles following microinjection of the pmHMG1-luc plasmid into one-cell pronuclei, and by open squares after injection of the same plasmid into one nucleus of two-cell embryos. In parentheses below each time point, the number of embryos analyzed is given to the left of the slash and the percentage of responding embryos is given to the right. RLU, relative light units.
contrast, whereas HMG1 decreases in concentration following ZGA in Xenopus embryos, it increases in concentration following ZGA at the two-cell stage in mouse embryos. When combined with studies on HMG1 in somatic cells, these results are not in agreement with the proposal of a simple, shared structural role for HMG1 and histone H1 in mammalian chromatin.
Experimental procedures
RT-PCR and Northern blotting
At each developmental stage, RNA was extracted from 70 embryos using the RNA PLUS kit (Bioprobe) with 10 mg of 5S-ribosomal RNA added as a carrier. Reverse transcription was performed in 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 500 mM dNTP, 2 mM of a linker-oligo(dT) (5′-CTCGGAATTCCGGT 18 -3′), 25 U RNase inhibitor, and 250 U M-MLV reverse transcriptase (Gibco-BRL), in a volume of 25 ml for 1 h at 37°C. Reverse transcription reactions were stopped by incubation at 95°C for 5 min. PCR reactions were carried out in 10 mM Tris-HCl pH 8.8, 50 mM KCl, 1.5 mM MgCl 2 , 0.1% Triton X-100, 100 mM dNTP, 1 mM of a primer complementary to part of the linker-oligo(dT) (5′-CTCGGAATTCCGGTT-3′), 1 mM of a specific primer, and 1 U Taq polymerase (Bioprobe), in a volume of 50 ml. The PCR program consisted of an incubation at 94°C for 6 min, followed by cycles at 94°C for 30 s, 57°C for 30 s and 72°C for 40 s, with a final incubation at 72°C for 5 min. To amplify cDNA synthesized from the 2.5 kb hmg1 transcript, cDNA derived from an equivalent of 15 embryos was used with the specific primer 5′-CCTATACTGTGGTTTGTCCCT-3′, and 25 cycles of PCR were done. The cDNAs from the 1.5 and 1.2 kb hmg1 transcripts were amplified using cDNA derived from an equivalent of 25 embryos, using the specific primers 5′-CTTCAGTTGTCTCTGATGCAG-3′ and 5′-TGG-TCAAGGCTGAAAAGAGCA-3′, respectively, and 30 cycles of PCR. For each transcript, the number of cycles used was in the linear range of amplification. Mouse kidney cDNA was amplified under the same conditions using equivalents of 22 ng or 37 ng, when corresponding equivalents 15 or 25 embryos were used. One fifth of the PCR products were loaded on 1.8% agarose gels, transferred onto nylon (N + ) membranes, and hybridized with an excess of labeled probe containing the corresponding fragment of hmg1 cDNA. Signals were quantified using a phosphorimager (Molecular Dynamics). Aliquots of 18 mg of total RNA isolated from kidney and 3T3 cells were separated on a 1.2% agarose gel, transferred onto a nylon (N + ) membrane and hybridized at 65°C with a labeled HMG1 probe containing exon 5 in 1% SDS, 2× SSC, 1× Denhardt's, 100 mg/ml salmon sperm DNA, 10% dextran sulfate. Membranes were washed in 2× SSC, 0.1% SDS, followed by 0.2× SSC, 0.1% SDS.
Plasmids
The pmHMG1tag plasmid has been described (Falciola et al., 1997) . The pmHMG1-luc plasmid was constructed in several steps using standard techniques (Fig. 1A) . Briefly, Fig. 7 . Luciferase expression from a single developing embryo microinjected with pmHMG1-luc. The embryo was injected at the one-cell stage and was imaged repeatedly throughout the preimplantation period. In the upper panels are transmission images of the embryo at the two-cell (2c), four-cell (4c), morula and blastocyst stages. Directly below each transmission image are corresponding photon counting images (Hamamatsu Photonics, Argus-50 system). Signal intensity is pseudocolor-coded, and ranges from low (blue) to high (red). Gain settings were identical for all photon counting images, and the integration times (s) are given in the bottom left corner of each image. the genomic 3.4 kb EcoRI-HindIII fragment from pm HMG1tag, encompassing 1.1 kb upstream of the major transcriptional start site, the first exon, the first intron and part of the second exon of the mouse hmg1 gene, was cloned in the pCAT-MOS plasmid (Meroni et al., 1996; Reue et al., 1988) between the SmaI and the HindIII sites. The HindIII-BamHI fragment of the pGL3 plasmid (Promega), containing the modified cytosolic firefly luciferase coding sequence and the SV40 polyadenylation signal, was then cloned downstream of the hmg1 sequences. During cloning the 62 bp HindIII-HindIII fragment spanning the end of intron 1 and the beginning of exon 2 of the hmg1 gene was reinserted. Correct orientation was confirmed by sequencing. The resulting plasmid, pmHMG1-luc, expresses a hybrid hmg1-luc-SV40 mRNA that codes uniquely for firefly luciferase without any addition or removal of amino acids.
Antibodies
The chicken anti-recAtn antibody directed against the native HMG1 protein was provided by H. Rauvala (Biotekniiken Instituutti, Helsinki, Finland) and has been previously described (Parkkinen et al., 1993; Falciola et al., 1997) . A second chicken anti-HMG1 affinity-purified polyclonal antibody, chIP-AB, was obtained as previously described (Falciola et al., 1997) . The mouse monoclonal antibody directed against the HA nonapeptide tag YPYDVPDYA was purchased from Boehringer Mannheim.
Embryo production, culture, and microinjection
F1 hybrid C57BL6/CBA males were mated with superovulated F1 hybrid C57BL6/CBA females and embryos were collected and cultured as previously (Thompson et al., 1994) . Prior to microinjection, plasmids were purified twice on cesium chloride gradients and dissolved at 25 ng/ml in 10 mM Tris-HCl pH 7.4, 0.1 mM EDTA. The pmHMG1-luc plasmid was injected into either one pronucleus of onecell embryos or one nucleus of two-cell embryos. The pmHMG1tag plasmid was only injected into one-cell pronuclei. For one-cell microinjections, embryos were collected at 22-24 h post human chorionic gonadotropin (hCG) injection and were microinjected with 1-2 pl of the appropriate plasmid. At the two-cell stage, microinjections were done at 44-45 h post hCG.
Luciferase expression and photon counting imaging
To determine the transcriptional activity of the hmg1 promoter during the preimplantation period, embryos which had been microinjected with pmHMG1-luc were individually lysed and frozen at the following times post hCG: two-cell at 43 or 48 h, four-cell at 65 h, eight-cell at 75 h, morula at 90 h, and blastocyst at 118 h. Luciferase assays were performed as described (Thompson et al., 1994) .
In order to follow transcriptional activity in the same embryo throughout the preimplantation period, luciferase expression was also assayed by photon counting imaging. At the times noted above, individually cultured microinjected embryos were rinsed in PB1 medium complemented with 500 mM firefly luciferin (Sigma) and placed in 2.5 ml drops of the same medium covered with mineral oil in a microscopic chamber. They were maintained at 37°C on a Zeiss Axiovert 135 inverted microscope coupled to the ARGUS 50 VIM-3 imaging system (Hamamatsu Photonics) in a dark room. After integration of the luminescent signal (for 10 s to 2 min, depending on signal intensity), the embryos were rinsed in PB1 and returned to the incubator for individual culture in microdrops. This same procedure was repeated for measurements at each developmental stage. Quantification of signals from each embryo was done in the area analysis mode on the Argus 50 system.
Photon counting imaging was also used to determine the half-life of the recombinant cytosolic luciferase produced by the pmHMG1-luc construct. Previously we had estimated the half-life of the peroxisome-targeted luciferase in mouse embryos to be less than 2 h; this was done by microinjecting purified native luciferase (Sigma) into the cytoplasm of embryos and assaying the time course of decay . In this study, embryos which had been microinjected with pmHMG1-luc at the one-cell stage were cultured to either the two-cell stage (42 h post hCG) or the four-cell stage (65 h post hCG). At these time points, further transcription was arrested by transferring embryos to medium containing 100 mg/ml aamanitin (Sigma). Embryos were maintained individually in culture under these conditions and photon counting imaging was performed as above at 3, 7, 11, and 24 h after inhibition was initiated. At each interval in the time course, 30 embryos were measured for both the two-and four-cell groups. Analysis of the resulting decay curves yielded an estimate of between 2 and 3 h for the half-life of the cytosolic luciferase in preimplantation embryos.
Confocal immunofluorescence microscopy and image analysis
Two different fixation protocols, ethanol/acetic acid or paraformaldehyde, were carried out on embryos as described . The only modification was that 2.5% paraformaldehyde fixation was for 20 min at room temperature. Blocking, antibody incubations, washing, and nuclear counterstaining were as previously described. Observations were made on a Zeiss confocal laser scanning microscope LSM-310 with a Zeiss plan neofluor 63X (NA 1.4) oil immersion objective.
With the exception of nucleoli, where staining with anti-HMG1 was absent, serial optical sectioning of nuclei at each developmental stage revealed that HMG1 was homogeneously distributed in the nucleoplasm throughout the nuclear volume. Therefore, to do semi-quantitative analysis of the relative levels of native HMG1 in nuclei from the one-cell stage through to the blastocyst stage, median sections through nuclei were analyzed. After correction of signal intensity for the distance in z of the section from the objective, manual outlining of the nucleoplasm, with the exclusion of nucleoli, was done using Argus 50 software; quantification was performed in the area analysis mode.
